Preclinical Prostate Cancer Models

In vitro and in vivo models of prostate cancer for translational preclinical research and drug discovery

Advanced Drug Development with Translational Models of Prostate Cancer

Prostate cancer is a highly heterogeneous and complex disease, presenting serious challenges to preclinical drug development and biomedical research. Our suite of prostate cancer models helps you recapitulate all phases of disease progression and evaluate potential therapies for each, so your team can advance into clinical trials with confidence.

Prostate Cancer Cell Lines 

Cell Line Derived Xenograft Models 

Patient-Derived Xenograft Models 

Prostate Cancer Immunotherapy Assessment 

Open Prostate Cancer Model Databases 

Additional Prostate Cancer Resources


New Advancements in Preclinical Prostate Cancer PDX Models
>> Read Now


Patient-Derived Xenografts: New Advancements in Preclinical Prostate Cancer Models
>> Watch Now
progression of prostate cancer from initiation to metastatic, castration resistant disease, including genetic alterations and cellular processes


Why Are Prostate Cancer Preclinical Models Hard to Develop?
>> Read Now
immunohistochemistry images showing that prostate cancer pdx models retain the structure of original patient tumors


Prostate Cancer Patient-Derived Xenograft (PDX) Models
>> Read Now


Prostate Cancer Patient-Derived Xenograft and Cell Line Model Validation
>> Read Now

Discuss Your Prostate Cancer Project